However, the results differed from those of previous studies reporting that the AMPK pathway was downstream of Erk1/2 signaling during nanomaterial-induced osteogenesis [32] and the AMPK pathway negatively regulated the Erk1/2 signal by suppressing B-raf on melanoma [33]. The gene discussed is MAPK3; the disease is melanoma.